Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | ALB | P02768 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.47 |
| ▸ | TYMP | P19971 | 3/20 | 0.42 |
| ▸ | STING1 | Q86WV6 | 3/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.37 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9548837 | 0.85 | ADORA3 (0.49) | ADORA3STING1HPRT1PNP | |
| SCHEMBL9548850 | 0.85 | ADORA3 (0.49) | ADORA3STING1HPRT1PNP | |
| SCHEMBL9548816 | 0.82 | ALDH1A1 (0.61) | ALDH1A1LMNAALBMAPK1ADORA3 | |
| SCHEMBL9548610 | 0.82 | PI4K2A (0.49) | ALDH1A1MAPK1ADORA3 | |
| SCHEMBL9548599 | 0.82 | PI4K2A (0.49) | ALDH1A1MAPK1ADORA3 | |
| SCHEMBL9548794 | 0.79 | AHCY (0.43) | LMNAALBADORA3PNP | |
| SCHEMBL9548783 | 0.78 | ALDH1A1 (0.56) | ALDH1A1LMNAALBMAPK1ADORA3 | |
| SCHEMBL9152200 | 0.78 | ALDH1A1 (0.56) | ALDH1A1LMNAALBMAPK1ADORA3 | |
| SCHEMBL9548798 | 0.74 | ALDH1A1 (0.45) | ALDH1A1LMNAALBMAPK1ADORA3 | |
| SCHEMBL15075488 | 0.73 | ADORA3 (0.51) | ADORA3STING1HPRT1PNP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5192749-A | Viricide, AIDS | SYNTEX (U.S.A.) INC. (US) | 1993-03-09 | — | — | US | disclosed |